Skip to Content

KX52 (Auryxia 210 mg (ferric iron))

Generic Name: ferric citrate

Pill imprint KX52 has been identified as Auryxia 210 mg (ferric iron).

Auryxia is used in the treatment of hyperphosphatemia of renal failure and belongs to the drug class phosphate binders. There is no proven risk in humans during pregnancy. Auryxia 210 mg (ferric iron) is not a controlled substance under the Controlled Substance Act (CSA).

Auryxia 210 mg (ferric iron) KX52
Discount Card Promo
Auryxia
Generic Name:
ferric citrate
Imprint:
KX52
Strength:
210 mg (ferric iron)
Color:
Peach
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Phosphate binders
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Keryx Biopharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide